Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer
Yuan Jiang(University of Science and Technology of China), Sigal Gery(Cedars-Sinai Medical Center), De‐Chen Lin(Cedars-Sinai Medical Center), Zhihao Lü(Nanjing Tech University), Yueyuan Zheng(University of Science and Technology of China), Yuan‐Wei Zhang(Sun Yat-sen University), Benjamin Ziman(University of Southern California), Shuai Kong(University of Science and Technology of China), Allen S. Ho(Cedars-Sinai Medical Center), Wenqiang Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Masaharu Hazawa(Kanazawa University), Ming‐Rong Wang(Capital University of Economics and Business), H. Phillip Koeffler(Cedars-Sinai Medical Center), Huaguang Pan(Kanazawa University), Chuntong Yin(University of Science and Technology of China), Jian Chen(University of Southern California), Jianian Zhou(University of Science and Technology of China), Dan Zhou(Xiamen University), Fei Wang(University of Science and Technology of China), Uttam K. Sinha(University of Southern California), Dan‐Dan Wei(Anhui Medical University), Yan-Yi Jiang(University of Science and Technology of China), Jia‐Jie Hao(Cedars-Sinai Medical Center), Jinxiu Dong(University of Science and Technology of China), Shuo Zhang(University of Science and Technology of China)
Cited by 34
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020
|Cancer Communications|2021|1.1k
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k